Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Obesity Pill to Replace Injections
Description
Novo Nordisk's high-dose experimental obesity pill, an oral version of semaglutide, helps overweight or obese adults lose 15% of their body weight when used with diet and exercise. Offering a more convenient alternative to injections, the pill could help individuals struggling to lose weight and address the significant health concern of obesity.
More from User
01:07
Adobe Beats Q2
Benzinga
00:58
NVIDIA's New AI PC Chip
Benzinga
01:01
SpaceX Trims Retail Slice
Benzinga
00:58
Judge Rejects Pirro
Benzinga
01:05
Musk First Trillionaire?
Benzinga
00:58
Coinbase Launches AI Agent
Benzinga
Related Videos
00:45
Novo Nordisk cuts supply of obesity drug Wegovy in the US due to surging demand
Benzinga
00:42
Weight Loss Bubble? Investors Bullish on Novo Nordisk and Eli Lilly as Obesity Epidemic Drives Sales of Ozempic and Wegovy
Benzinga
11:14
Novo CEO Sees Strong Demand for Wegovy Obesity Pill
Bloomberg
03:02
Novo Gets Approval to Sell Wegovy Obesity Pill in the US
Bloomberg
05:35
Health Nest /Obesity/what is obesity?obesity causes?obesity treatment?motapa?motapay ka Ilaj in Urdu
Health Nest
00:33
Obesity Treatment | Obesity Treatment in Hindi | Motapa ka ilaj | DM Health Solutions | Dr. Israr Ahmad Rana | #doctor | #obesity | #trending | #viral | #trends
DM Health Solutions